MSD (PTY) LTD

South Africa

117 16th St, Halfway House Estate, Midrand, 1685, South Africa

Midrand, South Africa

Maps

122

Total Medicines

Active

Dosage Forms

Countries

South Africa (61) Kenya (18) Botswana (17) Tanzania (13) Zimbabwe (8) Uganda (4) Zambia (1)

Location

117 16th St, Halfway House Estate, Midrand, 1685, South Africa

Open in OpenStreetMap approx.

Registration Status

Registered 96

Canceled 16

PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) 6

PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) 2

Withdrawn 2

Dosage Forms

TABLETS 12 TABLET 5 Suspension for injection 4 TABLET; ORAL 3 Tablets, Chewable 2 Tablets 2 SOLUTION; INJECTION 2 ORAL SOLID ORDINARY CHEWABLE TABLETS 2

Therapeutic Classes

NEW/INNOVATOR 16

Local Agents / Applicants

MSD (Pty) Ltd 61

MSD (PTY) LTD 41

ORGANON SOUTH AFRICA (PTY)... 17

MSD (PVT) SOUTH AFRICA 1

Distributing Wholesalers

Licensed wholesalers / distributors that carry this MAH's brands.

Eastleigh Pharmaceutical

Eastleigh, Nairobi

7 SKUs

Generics Africa

Nairobi

2 SKUs

Browse all wholesalers

Registered Medicines

Showing 20 of 122 · Page 3 of 7

Search all

Product	Form / Strength	Country	Reg. Number	Status
GARDASIL HUMAN PAPILLOMAVIRUS (HPV)	SOLUTION; INJECTION 9 - valent	Zimbabwe	2025/18.2/6989	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
GARDASIL 9 HUMAN PAPILLOMAVIRUS (HPV) 9-VALENT VACCINE	EACH 0.5 ML DOSE CONTAINS APPROXIMATELY: 30 MCG HPV TYPE 6 L1 PROTEIN, 40 MCG HPV TYPE 11 L1 PROTEIN, 60 MCG HPV TYPE 16 L1 PROTEIN, 40 MCG HPV TYPE 18 L1 PROTEIN, 20 MCG HPV TYPE 31 L1 PROTEIN, 20 MCG HPV TYPE 33 L1 PROTEIN, 20 MCG HPV TYPE 45 L1 PROTEIN, 20 MCG HPV TYPE 52 L1 PROTEIN, 20 MCG HPV TYPE 58 L1 PROTEIN.	Kenya	H2025/CTD12769/26449	Registered
GARDASIL 9 HUMAN PAPILLOMAVIRUS (HPV) 9-VALENT VACCINE	EACH 0.5 ML DOSE CONTAINS APPROXIMATELY : 30 MCG HPV TYPE 6 L1 PROTEIN 40 MCG HPV TYPE 11 L1 PROTEIN, 60MCG HPV TYPE 16 L1 PROTEIN, 40 MCG HPV TYPE 18 L1 PROTEIN, 20 MCG HPV TYPE 31 L1 PROTEIN, 20 MCG HPV TYPE 33 L1 PROTEIN, 20 MCG HPV TYPE 45 L1 PROTEIN, 20 MCG HPV TYPE 52 L1 PROTEIN, 20 MCG HPV TYPE 58 L1 PROTEIN.	Kenya	H2025/CTD12746/26444	Registered
GARDASIL 9 HPV TYPE 6;11;16;18;31; 33;45;52;58 L1 PROTEIN	-	South Africa	51/30.1/0264	Registered
GARDASIL 9 HUMAN PAPILLOMAVIRUS (HPV)	SOLUTION; INJECTION 9 - valent	Zimbabwe	2025/18.2/7028	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
Gardasil Human Papillomavirus type 11 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 16 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 18 L1 Protein 20 mcg/0.5ml,Human Papillomavirus type 6 L1 Protein 20 mcg/0.5ml,L-Histidine 0.78 ml/100ml,Polysorbate 80 50 mcg/ml,Sodium Borate 35 mcg/ml,Sodium Chloride 9.56 ml/100ml	Injection	Tanzania	TAN 09,180 J07A MSD	Registered/Compliant
Gardasil Amorphous aluminum hydroxy-phosphate sulfate adjuvant 225 μg (aluminum content) per 0.5-mL dose,HPV 11 L1 protein 40 mcg/ml,HPV 16 L1 protein 40 mcg/ml,HPV 18 L1 20 mcg/ml,HPV 6 L1 protein 20 mcg/ml,L-Histidine 0.78 mg per 0.5-mL dose,Polysorbate 80 50 μg per 0.5-mL dose,Sodium Borate 35 μg per 0.5-mL dose,Sodium Chloride USP 9.56 mg per 0.5-mL dose,Water for Injection QS dose	Suspension for injection	Tanzania	TAN 22 V 0259	Registered/Compliant
Gardasil Aluminium hydroxy-phosphate sulfate 225 mcg/ml,Human Papillomavirus type 11 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 16 L1 Protein 20 mcg/0.5ml,Human Papillomavirus type 18 L1 Protein 20 mcg/0.5ml,Human Papillomavirus type 6 L1 Protein 20 mcg/0.5ml,L-Histidine 0.78 ml/100ml,Polysorbate-80 50 mcg/ml,Sodium Borate 35 mcg/ml,Sodium Chloride 225 mcg/ml,Water for injections qs	Suspension for injection 20/40/20/20	Tanzania	TAN 22 V 0513	Registered/Compliant
Gardasil Aluminium hydroxy-phosphate sulfate 225 mcg/ml,Human Papillomavirus type 11 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 16 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 18 L1 Protein 20 mcg/0.5ml,Human Papillomavirus type 6 L1 Protein 20 mcg/0.5ml,L-Histidine 0.78 ml/100ml,Polysorbate 80 50 mcg/ml,Sodium Borate 35 mcg/ml,Sodium Chloride 9.56 ml/100ml	Injection	Tanzania	TAN 09,288 J07A MSD	Registered/Compliant
Gardasil 9 Amorphous aluminum hydroxyphosphate sulfate adjuvant 500 micrograms,HPV Type 11 L1 Protein 40 microgram,HPV Type 16 L1 Protein 60 microgram,HPV Type 18 L1 Protein 40 microgram,HPV Type 31 L1 Protein 20 microgram,HPV Type 33 L1 Protein 20 microgram,HPV Type 45 L1 Protein 20 microgram,HPV Type 52 L1 Protein 20 microgram,HPV Type 58 L1 Protein 20 microgram,HPV Type 6 L1 Protein 30 micrograms,L-Histidine 0.78 microgram,Polysorbate 80 USP-NF/Ph.Eur. 50 microgram,Sodium Chloride. 9.56 microgram,Water for Injection QS QS	Suspension for injection	Tanzania	TAN 25 V 0208	Registered/Compliant
Gardasil 9 Amorphous aluminum hydroxyphosphate sulfate adjuvant 500 micrograms,HPV Type 11 L1 Protein 40 microgram,HPV Type 16 L1 Protein 60 microgram,HPV Type 18 L1 Protein 40 micrograms,HPV Type 31 L1 Protein 20 micrograms,HPV Type 33 L1 Protein 20 micrograms,HPV Type 45 L1 Protein 20 micrograms,HPV Type 52 L1 Protein 20 micrograms,HPV Type 58 L1 Protein 20 micrograms,HPV Type 6 L1 Protein 30 microgram,L-Histidine 0.78 mg/6 mL,Polysorbate-80 50 micrograms,Sodium Borate 35 micrograms,Sodium Chloride 9.56 mg/6 mL,Water for Injection quantity q.s	Suspension for injection	Tanzania	TAN 25 V 0209	Registered/Compliant
H-B-VAX II 0,5 None	-	South Africa	V/30.1/236	Canceled
H-B-VAX II 1,0 None	-	South Africa	V/30.1/237	Canceled
INEGY 10/10 MG EZETIMIBE/SIMVASTATIN	10 MG EZETIMIBE/10 MG SIMVASTATIN PER TABLET	Kenya	H2016/CTD2175/389	Registered
INEGY 10/20 MG EZETIMIBE/SIMVASTATIN	10 MG EZETIMIBE/20 MG SIMVASTATIN PER TABLET	Kenya	H2016/CTD2173/387	Registered
INEGY 10/40 MG EZETIMIBE/SIMVASTATIN	10 MG EZETIMIBE/40 MG SIMVASTATIN PER TABLET	Kenya	H2016/CTD2174/388	Registered
INTEGRILIN 0,75 mg/ml INJECTION None	-	South Africa	31/8.2/0539	Canceled
INTEGRILIN 2 mg/ml INJECTION None	-	South Africa	31/8.2/0540	Canceled
INVANZ None	-	South Africa	37/20.1.1/0424	Registered
ISENTRESS None	-	South Africa	42/20.2.8/0687	Registered

Prev 1 2 3 4 5 ... 7 Next

122 products